Dihydrobenzofluorene compounds, intermediates, compositions and methods
申请人:Eli Lilly and Company
公开号:US05792762A1
公开(公告)日:1998-08-11
The invention provides dihydronaphthofluorene compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related pathological conditions.
Naphthalene compounds, intermediates, formulations, and methods
申请人:Eli Lilly and Company
公开号:US06599920B2
公开(公告)日:2003-07-29
This invention relates to the field of pharmaceutical and organic chemistry and provides naphthalene compounds, intermediates, formulations, and methods.
本发明涉及制药和有机化学领域,提供了萘化合物、中间体、制剂和方法。
Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods of preparation thereof.
申请人:ELI LILLY AND COMPANY
公开号:EP0826680B1
公开(公告)日:2001-10-24
US5958917
申请人:——
公开号:——
公开(公告)日:——
Dihydrobenzofluorene compounds, intermediates, compositions, and methods